Determination of Extractable Volatile Organic Compounds by Headspace GC/MS

Headspace Gas Chromatography–Mass Spectrometry (Headspace GC/MS) is a specialized technique used to detect and semi-quantify volatile organic compounds (VOCs) that may be released from medical device materials. By heating the device in a sealed vial, VOCs are vaporized into the headspace and analyzed without direct contact with solvents. This method is highly sensitive and ideal for identifying residual solvents, monomers, and other low-boiling compounds. Headspace GC/MS supports toxicological risk assessments and regulatory submissions by providing a detailed chemical profile of volatiles that could pose safety risks during clinical use.

Why This Testing is Performed

This test is performed to identify VOCs that may migrate from medical devices under simulated use conditions. These compounds can be harmful if inhaled or absorbed, making their detection critical for biocompatibility evaluations. Headspace GC/MS helps manufacturers ensure product safety and meet regulatory expectations for chemical characterization.

Have you tried our Test Navigator Tool? Try it now

Steps in Conducting This Test

1. Sample Preparation: Devices are placed in sealed vials without solvents.
2. Heating: Vials are heated to release VOCs into the headspace.
3. Headspace Sampling: The vapor phase is sampled and injected into the GC/MS system.
4. Separation: VOCs are separated in the gas chromatograph based on volatility.
5. Detection: Mass spectrometry identifies compounds by their mass-to-charge ratio.
6. Quantification: Concentrations are estimated using external standards.
7. Data Interpretation: Results are compared to toxicological thresholds for risk assessment.

Standards, Guidance, and Regulations

• ISO 10993-18:2020: Defines requirements for chemical characterization, including volatile analysis.
• FDA Guidance: Recommends using diverse VOC reference standards and avoiding internal standard spiking due to vapor-phase partitioning concerns.
• ICH M7: Supports the use of Analytical Evaluation Thresholds (AETs) for identifying compounds requiring toxicological review.